Vasoactive Intestinal Peptide in Checkpoint Inhibitor–Induced Pneumonitis
Björn C. Frye, Frank Meiß, Dagmar von Bubnoff, Gernot Zissel, Joachim Müller–Quernheim
Abstract
Inhaled Vasoactive Intestinal Peptide for Checkpoint Inhibitor Pneumonitis A patient with severe autoimmune pneumonitis from immune checkpoint inhibitor therapy for metastatic melanoma had improved...
Topics & Concepts
MedicinePneumonitisVasoactive intestinal peptideMelanomaCancer researchInternal medicineLungReceptorNeuropeptideCancer Immunotherapy and BiomarkersInhalation and Respiratory Drug DeliveryImmunotherapy and Immune Responses